PATENT CLAIM ANALYSIS

Application Number: 16002364
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "137100"]

Abstract:
The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.

Claim (Index 110):
The method of  claim 109 , wherein said detectable label is selected from the group consisting of immunofluorescent label, chemiluminescent label, phosphorescent label, enzyme label, radiolabel, luminophore, avidin/biotin, colloidal gold particles, colored particles, and magnetic particles.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 94.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15473008', '14473828', '14921596', '15620117', '14015653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.815059754136842
- 35 USC 102 Novelty (BERT): 0.6441337040476595
- Combined Prediction Score: 0.7979671491279237
- Mean Citation Score: 555.782786
- Max Citation Score: 684.2430400000002
- Similarity Product: 555.6136932256319

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test